Indefinite Delivery Contract SPE2DB22D9631
Award Date 5/19/22
Last Date to Order 12/31/25
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The Indefinite Delivery Contract was awarded as a single award by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. With a potential value of $499,999,999, the contract supports the Prime Vendor Pharmaceutical Branch in Philadelphia through December 31, 2025. The SPE2DB program aims to procure pharmaceutical products and services for the Defense Logistics Agency through a prime vendor arrangement. DMS Pharmaceutical Group Inc. will deliver pharmaceuticals and manage distribution to...
- The Defense Logistics Agency awarded a single award indefinite delivery contract to DMS Pharmaceutical Group Inc. with a potential value of $499,999,999 to serve as a prime vendor for pharmaceutical products and services. The contract has a period of performance through December 2025. Under the contract, DMS Pharmaceutical Group will supply pharmaceuticals to military treatment facilities from its distribution center in Philadelphia, Pennsylvania on an as-needed basis. One such order awarded...
- The Indefinite Delivery Contract was awarded as a single award by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc. The contract has a potential value of $4,999,999 and a period of performance through December 31, 2025. The SPE2DX contract provides pharmaceutical products and services to the Prime Vendor Pharmacy Branch located in Philadelphia, Pennsylvania. As a prime vendor contract, it establishes DMS Pharmaceutical Group Inc. as the primary supplier for...
- The Defense Logistics Agency awarded a single-award indefinite-delivery/indefinite-quantity contract to DMS Pharmaceutical Group Inc. to supply pharmaceutical products and services in support of Department of Defense programs. The contract has a potential value of $499,999,999 and period of performance through December 2025. The task orders issued against the contract by DLA between June and July 2022 procured a range of pharmaceutical products for delivery to locations in Park Ridge,...
- The Defense Logistics Agency (DLA) has awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 under the SPE2DB program. This IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs...
- The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC, awarded under the SPE2DB program, covers an extensive portfolio of branded and...
- The Indefinite Delivery Contract was awarded as a single award by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc. to serve as the prime vendor for pharmaceutical branch services in Philadelphia. With a potential value of $4,999,999, the contract utilizes no set-asides and has a period of performance through task order delivery by December 30, 2025. Under contract number 4600080777, DMS Pharmaceutical Group Inc. will provide pharmaceutical products and...
- The Defense Logistics Agency awarded a single-award, indefinite delivery contract to DMS Pharmaceutical Group Inc. The contract provides for the delivery of various pharmaceutical products and medical supplies in support of DLA's global supply chain management for the Department of Defense. Over the five year potential value of $4,999,999, DLA issued firm fixed price delivery orders against the contract for contraceptives, vaccines, injectable drugs, and medical consumables. Delivery locations...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, under the SPE2DR program, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. Through this contract, DMS Pharmaceutical...